医学
药物基因组学
VKORC1型
氯吡格雷
CYP2C19型
阿司匹林
药物遗传学
药品
重症监护医学
疾病
基因检测
华法林
个性化医疗
药理学
内科学
生物信息学
CYP2C9
基因型
生物
基因
遗传学
细胞色素P450
新陈代谢
心房颤动
出处
期刊:Chinese Journal of Laboratory Medicine
日期:2015-07-11
卷期号:38 (7): 442-444
标识
DOI:10.3760/cma.j.issn.1009-9158.2015.07.004
摘要
Common drugs for cardiovascular disease include aspirin, clopidogrel, warfarin, nitroglycerin and statins etc.Because of individual differences, the effect of same drug treatment in different patients is not the same, and more and more studies found that genetic factors were important reasons to cause the efficacy of individual differences.The single nucleotide polymorphisms of important genes such as COX-1, GPⅡb/Ⅲa, CYP2C19, CYP2C9, VKORC1, ALDH2 and that relate to drug absorption, distribution, metabolism as well as excretion have been discovered.Development of clinical gene detection and the implementation of individualized drug treatment based on genetic test results will significantly improve the therapeutic effect. The development of individualized medicine in the future on the above basis has important clinical value.(Chin J Lab Med, 2015, 38: 442-444)
Key words:
Cardiovascular disease; Genetic testing; Polymorphism, genetic
科研通智能强力驱动
Strongly Powered by AbleSci AI